Norwegian Centre for Addiction Research (Seraf), University of Oslo, Norway; Vestli Isolation Unit, Agency for Social and Welfare Services, Municipality of Oslo, Norway.
Norwegian Centre for Addiction Research (Seraf), University of Oslo, Norway; Norwegian Institute of Public Health, Norway.
Drug Alcohol Depend. 2020 Dec 1;217:108302. doi: 10.1016/j.drugalcdep.2020.108302. Epub 2020 Sep 18.
Little is known regarding what people who use drugs (PWUD) know about COVID-19 related issues and changes in the drug market due to COVID-19. We therefore conducted a survey to explore these issues.
In a cross-sectional study, we interviewed 226 PWUD from three Norwegian cities in May/June 2020. Participants completed an interview-administrated questionnaire. Three separate multiple binary logistic regression models were estimated with the outcomes (no/yes): 1. Familiarity with COVID-19 symptoms, 2. Awareness of COVID-19 services tailored towards PWUD and, 3. Willingness to take a COVID-19 test.
The mean age was 44.1 years and 73 % were males. Fifty-four percent were injectors, and heroin/other opioids (35.8 %) and cocaine/amphetamine (25.2 %) were the most common main drugs used. Overall, 54.9 % were in opioid maintenance treatment (OMT). The majority (65.9 %) stated they knew the COVID-19 symptoms. Almost all the participants (91.2 %) reported they would take a COVID-19 test if experiencing relevant symptoms. The majority (63.7 %) were not aware of COVID-19 services available to PWUD. OMT patients were more likely to be familiar with COVID-19 symptoms (aOR = 3.4, 95 % CI 1.7; 6.8), and to be aware of COVID-19 services (aOR = 2.7, 95 % CI 1.1; 6.3). Overall, 35.4 % reported reduced drug availability, mainly for tranquilizers, while 61.5 % reported increased drug prices, mainly for cannabis.
Drug treatment may play an important role in COVID-19 prevention, as those in OMT were more likely to be aware of symptoms and of availability of services.
由于 COVID-19，人们对吸毒者（PWUD）对 COVID-19 相关问题和毒品市场变化的了解知之甚少。因此，我们进行了一项调查来探讨这些问题。
在一项横断面研究中，我们于 2020 年 5 月/6 月在挪威的三个城市采访了 226 名吸毒者。参与者完成了一份访谈式问卷调查。使用三个单独的多项二项逻辑回归模型来估计结果（是/否）：1. 对 COVID-19 症状的熟悉程度，2. 对针对 PWUD 的 COVID-19 服务的认识，3. 接受 COVID-19 检测的意愿。
参与者的平均年龄为 44.1 岁，73%为男性。54%为注射吸毒者，最常用的主要药物是海洛因/其他阿片类药物（35.8%）和可卡因/苯丙胺（25.2%）。总体而言，54.9%的人正在接受阿片类药物维持治疗（OMT）。大多数人（65.9%）表示知道 COVID-19 的症状。几乎所有参与者（91.2%）表示如果出现相关症状，他们会接受 COVID-19 检测。大多数人（63.7%）不知道针对 PWUD 的 COVID-19 服务。OMT 患者更有可能熟悉 COVID-19 症状（优势比[aOR] = 3.4，95%置信区间[CI] 1.7; 6.8），并了解 COVID-19 服务（aOR = 2.7，95% CI 1.1; 6.3）。总体而言，35.4%的人报告药物供应减少，主要是镇静剂，而 61.5%的人报告药物价格上涨，主要是大麻。
药物治疗可能在 COVID-19 预防中发挥重要作用，因为接受 OMT 的人更有可能了解症状和服务的可用性。
